MBX Biosciences Common Stock Overview
MBX Biosciences Common Stock Target Price
Analysts' 12-month price predictions for MBX.
Get informed when a big investor buys or sells
+ FollowShare Price
$57.8
Average Target Price
$61.50
6.4% upside
6.4% upside4 analysts in the last 4 months
High: $70 | Low: $50
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-12 | Stifel Nicolaus | $56 |  3.1% downside |  |
| 2026-05-12 | Barclays | $70 | 21.1% upside | |
| 2026-05-11 | Truist FinancialSrikripa Devarakonda | $70 | 21.1% upside | |
| 2026-03-09 | Truist FinancialSrikripa Devarakonda | $50 | 13.5% downside | |
| 2026-01-27 | Barclays | $66 | 14.2% upside | |
| 2026-01-16 | GuggenheimSeamus Fernandez | $88 | 52.2% upside | |
| 2026-01-07 | UBSMichael Yee | $60 | 3.8% upside | |
| 2025-12-19 | Stifel NicolausAnnabel Samimy | $50 | 13.5% downside | |
| 2025-12-04 | Goldman Sachs | $18 | 68.9% downside | |
| 2025-08-05 | Mizuho Securities | $38 | 34.3% downside | |
| 2024-10-08 | GuggenheimSeamus Fernandez | $44 | 23.9% downside | |